Biotech ETF

The U.S. reported its first human death from the H5 bird flu strain this week, causing a spike in vaccine developer stocks Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), CureVac (NASDAQ:CVAC) and Pfizer (NYSE:PFE). Vaccine production efforts are ramping up as health officials monitor the outbreak...

The single hottest large-cap exchange-traded fund, the SPDR S&P Biotech (ETF) (NYSE: XBI), is up more than 40 percent since the start of 2017 and by 10 percent in the past two weeks alone. Many investors aren't willing to assume the inherent risk that comes with investing in highly volatile...